shadow_tr

Breast Studies
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

PENELOPEB
Phase III Study Evaluating Palbociclib (PD-0332991), A Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor in Patients With Hormone-Receptor-Positive, HER2-Normal Primary Breast Cancer With High Relapse Risk After Neoadjuvant Chemotherapy

NRG-BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
More Information


ECOG E2112

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Postmenopausal Patients With Hormone Receptor-Positive Advanced Breast Cancer
More Information


 

 

1430 Tulane Ave, New Orleans, LA 70112 medsch@tulane.edu